TITLE

A new clinical rating scale for work absence and productivity: validation in patients with major depressive disorder

PUB. DATE
January 2009
SOURCE
BMC Psychiatry;2009, Vol. 9, p78
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
47316444

 

Related Articles

  • Multiple sclerosis, disease modifying treatments and depression: a critical methodological review. Feinstein, A. // Multiple Sclerosis (13524585);Oct2000, Vol. 6 Issue 5, p343 

    Background: Major depression affects one in two patients with multiple sclerosis (MS) during the course of their lifetime. This adds to the morbidity associated with the disorder and may contribute to an increased mortality rate because of suicide. Over the past few years, with the advent of...

  • Successful treatment must address physical symptoms in MDD.  // PharmacoEconomics & Outcomes News;7/16/2005, Issue 482, p13 

    Discusses research being done on treatment for patients with major depressive disorder (MDD). Scales used to determine clinical status; Comparison between the remission rates of MDD patients with painful physical symptoms and that of MDD patients without pain.

  • The Depressive Psychopathology Scale: presentation and initial validation in a sample of Peruvian psychiatric patients. Vega-Dienstmaier, Johann M.; Stucchi-Portocarrero, Santiago; Valdez-Huarcaya, Nancy; Cabra-Bravo, Miriam; Zapata-Vega, Maria I. // Revista Panamericana de Salud Publica;Oct2011, Vol. 30 Issue 4, p317 

    Objective. Presentation and validation of the Depressive Psychopathology Scale (DPS), a new, Spanish-language psychometric inventory, in a sample of Peruvian psychiatric patients. Methods. From 1999 to 2001, the DPS, Zung Self-rating Depression Scale (ZSDS), and Major Depressive Disorder (MDD)...

  • The Depressive Psychopathology Scale: presentation and initial validation in a sample of Peruvian psychiatric patients. Vega-Dienstmaier, Johann M.; Stucchi-Portocarrero, Santiago; Valdez-Huarcaya, Nancy; Cabra-Bravo, Miriam; Zapata-Vega, Maria I. // Pan American Journal of Public Health;Oct2011, Vol. 30 Issue 4, p317 

    Objective. Presentation and validation of the Depressive Psychopathology Scale (DPS), a new, Spanish-language psychometric inventory, in a sample of Peruvian psychiatric patients. Methods. From 1999 to 2001, the DPS, Zung Self-rating Depression Scale (ZSDS), and Major Depressive Disorder (MDD)...

  • Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients. Honarmand, Kimia; Feinstein, Anthony // Multiple Sclerosis (13524585);Dec2009, Vol. 15 Issue 12, p1518 

    Detecting clinically significant symptoms of depression and anxiety in medically ill patients using self-report rating scales presents a challenge because of somatic confounders. The Hospital Anxiety and Depression Scale (HADS) was developed with this in mind, but has never been validated for a...

  • Development and Psychometric Evaluation of a Clinical Global Impression for Schizoaffective Disorder Scale. ALLEN, MICHAEL H.; DANIEL, DAVID G.; REVICKI, DENNIS A.; CANUSO, CARLA M.; TURKOZ, IBRAHIM; FU, DONG-JING; ALPHS, LARRY; ISHAK, JACK; BARTKO, JOHN J.; LINDENMAYER, JEAN-PIERRE // Innovations in Clinical Neuroscience;Jan2012, Vol. 9 Issue 1, p15 

    Objective: The Clinical Global Impression for Schizoaffective Disorder scale is a new rating scale adapted from the Clinical Global Impression scale for use in patients with schizoaffective disorder. The psychometric characteristics of the Clinical Global Impression for Schizoaffective Disorder...

  • PRELIMINARY STUDY OF A SCALE MEASURING DEPRESSION AND SOMATIC SYMPTOMS. Ching-I Hung; Li-Jen Weng; Yi-Jen Su; Chia-Yih Liu // Psychological Reports;Oct2006, Vol. 99 Issue 2, p379 

    This description concerns the development of a scale measuring depression and somatic symptoms and the selection of its items for a Taiwanese sample. 102 Taiwanese outpatients (28 men, 74 women) with major depressive disorder completed a 44-item preliminary scale. All had experienced a major...

  • Levomilnacipran Extended-Release: A Review of Its Use in Adult Patients with Major Depressive Disorder. Scott, Lesley // CNS Drugs;Nov2014, Vol. 28 Issue 11, p1071 

    Oral levomilnacipran extended-release (ER) [Fetzimaâ„¢], the more active enantiomer of milnacipran, is the most recent serotonin norepinephrine reuptake inhibitor to be approved in the USA for the treatment of adults with major depressive disorder (MDD). MDD is characterized by depression...

  • Impairment of endothelial protection by ischemic postconditioning in patients with major depressive disorder. Zhuo, Chuanjun; Wang, Ying; Tian, Hongjun; Wang, Xiaohui; Chen, Yuhui; Mao, Fuqiang // Canadian Journal of Physiology & Pharmacology;Sep2011, Vol. 89 Issue 9, p647 

    This study used a model of ischemia-reperfusion injury to the brachial artery endothelium to investigate whether the protective role of ischemic postconditioning (IPostC) is impaired in patients with major depressive episode. Flow-mediated dilation (FMD) was measured before and after...

  • The improved Clinical Global Impression Scale (iCGI): development and validation in depression. Kadouri, Alane; Corruble, Emmanuelle; Falissard, Bruno // BMC Psychiatry;2007, Vol. 7, p7 

    Background: The Clinical Global Impression scale (CGI) is frequently used in medical care and clinical research because of its face validity and practicability. This study proposes to improve the reliability of the Clinical Global Impression (CGI) scale in depressive disorders by the use of a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics